Mead Johnson Nutrition Company (NYSE:MJN) is a recommended buy at Credit Suisse on China concerns. The firm thinks the vanillin issue will not be of great effect. Shares are rated Outperform with a $98 price target.
Travelzoo Inc. (NASDAQ:TZOO): According to Benchmark Co., following tracking under its $12.5M gross estimate for the majority of last month, Travelzoo’s Local Deals segment jumped up at the end of the quarter, making estimated gross estimates around $12M. The firm also noted a distinct rise in direct deals and deals without voucher counts, which makes it more comfortable in its Q2 Local Deals revenue estimate of $32.5M gross. Nevertheless, Benchmark maintains a Hold rating on Travelzoo shares.
Ocz Technology Group Inc. (NASDAQ:OCZ): Piper Jaffray says now is an opportunity to purchase OCZ Technology, even though it lowered its price target for shares from $17 to $13 after the company’s report of Q1 results. Piper Jaffray thinks OCZ left $27M on the table at the finish of Q1 because of supply limitations, and some of the company’s initiatives are not included in its annual outlook. Piper maintains an Overweight rating on shares of OCZ Technology. Also, Credit Suisse lowered the stock Wednesday morning to Neutral.
Duke Energy Corporation (NYSE:DUK): Credit Suisse thinks the sell-off of late in Duke shares will turn around as negative developments are dispelled. Shares are rated Outperform with a price target of $76.50.
Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR): Jefferies thinks Citron Research’s pessimistic blog post Tuesday about Questcor included misleading and outdated arguments. The firm reports it still thinks the technical and commercial challenges facing generic competition for Questcor’s Acthar are notable. Jefferies maintains a Buy rating on the stock with a price target of $60.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.